Binding sites of valsartan, candesartan and losartan with angiotensin II receptor 1 subtype by molecular modeling

Life Sciences

Volumn 85, Issue 3-4, 2009, Pages 136-140

  Bhuiyan, Mohiuddin Ahmed ^a   Ishiguro, Masaji ^a   Hossain, Murad ^a   Nakamura, Takashi ^a   Ozaki, Masanobu ^a   Miura, Shin ichiro ^b   Nagatomo, Takafumi ^a  

^a NIIGATA UNIVERSITY OF PHARMACY AND APPLIED LIFE SCIENCES   (Japan)

^b FUKUOKA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

AT1 antagonists; Binding sites; Molecular modeling; Radioligand binding

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; ASPARAGINE; CANDESARTAN; GLUTAMINE; LOSARTAN; LYSINE; SERINE; VALSARTAN;

ARTICLE; BINDING SITE; DRUG RECEPTOR BINDING; DRUG STRUCTURE; HUMAN; HUMAN CELL; LIGAND BINDING; MOLECULAR MODEL; PROTEIN STRUCTURE;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; BENZIMIDAZOLES; BINDING SITES; CELL LINE; HUMANS; LOSARTAN; MODELS, MOLECULAR; PROTEIN CONFORMATION; RADIOLIGAND ASSAY; RECEPTOR, ANGIOTENSIN, TYPE 1; TETRAZOLES; VALINE;

EID: 67449168119     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2009.05.001     Document Type: Article

References (20)

1. Bumpus F.M., Catt K.J., Chiu A.T., DeGasparo M., Goodfriend T., Husain A., Peach M.J., Taylor Jr. D.G., and Timmermans P.B.M.W.M. Nomenclature for angiotensin receptors. A report of Nomenclature Committee of the Council for High Blood Pressure Research. Hypertension 17 (1991) 720-721
2. 50) of an enzymatic reaction. Biochemical Pharmacology 22 (1973) 3099-3108
3. Chiu A.T., Herblin W.F., McDall D.E., Ardecky R.J., Carini D.J., Duncia J.V., Pease L.J., Wong P.C., Wexler R.R., Johnson A.L., and Timmermans P.B.M.W.M. Identification of angiotensin receptor subtypes. Biochemical and Biophysical Research Communications 165 (1989) 196-203
4. De Gasparo M., Catt K.J., Inagami T., and Unger T.H. The International Union of Pharmacology: the angiotensin II receptors. Pharmacological Reviews 52 (2000) 415-472
5. Fierens F.L.P., Vanderheyden P.M.L., Gaborik Z., Minh T.L., De Backer J.-P., Hunyady L., Ijzerman A., and Vauquelin G. Lys199 mutation of the human angiotensin type 1 receptor differently affects the binding of surmountable and insurmountable non-peptide antagonists. Journal of Renin-Angiotensin-Aldosterone System 1 (2000) 283-288
6. Gordon T., and McInnes. Clinical advantage of valsartan. Cardiology 91 (1999) 14-18
7. 2-adrenoceptors. Pharmacology 58 (1999) 183-189
8. 1 receptors identifies amino acid residues attributable to the binding affinity for the nonpeptidic antagonist losartan. Molecular Pharmacology 1 (2002) 1404-1415
9. 1-adrenergic receptor subtypes by molecular modeling. Life Sciences 71 (2002) 2531-2541
10. Ishiguro M., Oyama Y., and Hirano T. Structural models of the photointermediates in the rhodopsin photocascade, lumirhodopsin, metarhodopsin I, and metarhodopsin II. European Journal of Chemical Biology 5 (2004) 298-310
11. John H., Jennifer N.H., Steven J.F., and Daniel K.Y. Identification of angiotensin II type 2 receptor domains mediating high-affinity CGP 42112A binding and receptor activation. Journal of Pharmacology & Experimental Therapeutics 298 2 (2001) 665-673
12. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 193 (1951) 265-275
13. Miura S., Fujino M., Hanazawa H., Kiya Y., Imaizumi S., Matsuo Y., Tomita S., Uehara Y., Karnik S.S., Yanagisawa H., Koike H., Komuro I., and Saku K. Molecular mechanism underlying inverse agonist of angiotensin II type I receptor. Journal of Biological Chemistry 281 28 (2006) 19288-19295
14. Nagatomo T., Ishiguro M., Ohnuki T., Hattori K., Hosohata Y., Takatsu N., Katayama H., and Watanabe K. Studies on relationship between chemical structure and β-blocking potency of bopindolol and its two metabolites. Life Sciences 62 (1998) 1597-1601
15. Palczewski K., Kumasaka T., Hori T., Behnke C.A., Motoshima H., Fox B.A., Trong I.L., Teller D.C., Okada T., Stenkamp R.E., Yamamoto M., and Miyano M. Crystal structure of rhodopsin: a G-protein coupled receptor. Science 289 (2000) 739-745
16. Peach M.J. Renin-angiotensin system. Biochemistry and mechanisms of action. Physiological Reviews 57 2 (1977) 313-370
17. 1 subtype, G protein coupled receptor. Chemistry & Biology 1 4 (1994) 211-221
18. Verheijen I., Fierens F.L.P., De Backer J.P., Vauquelin G., and Vanderheyden P. Interaction between the partially insurmountable antagonist valsartan and human recombinant angiotensin II type 1 receptors. Fundamental & Clinical Pharmacology 14 (2000) 577-585
19. 1 receptor interaction: further support by binding studies at low temperature. Biochemical Pharmacology 65 8 (2003) 1339-1341 (15)
20. Whitebread S., Mele M., Kamber B., and DeGasparo M. Preliminary biochemical characterization of two angiotensin II receptor subtypes. Biochemical and Biophysical Research Communications 163 (1989) 284-291